News | April 28, 2024
Evonik expands capacity for customized Resomer powder biomaterials
New solvent-free micronization technology expanded at the Darmstadt site in Germany
New solvent-free micronization technology expanded at the Darmstadt site in Germany
Desidustat, administered orally is a novel, oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in Chronic Kidney Disease (CKD) patients
Highly effective preservation solutions ensuring the safety and protection of personal care products
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
BHL will undertake the development and supply of these molecules
Sustainability is integral to Biocon's business purpose
iSolveSM information on demand is the result of our focus on customer relationship
This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)